#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA788236	F	Inhibition of bradykinin-induced dermal vascular permeability in rats at a peroral dose of 100 mg/kg 1 hr prior to challenge	Rattus norvegicus	7		organism-based format	Scientific Literature
2.	ALA787926	F	Inhibition of histamine -induced dermal vascular permeability in rats at a peroral dose of 100 mg/kg 1 hr prior to challenge	Rattus norvegicus	7		organism-based format	Scientific Literature
3.	ALA788047	F	Inhibition of serotonin -induced dermal vascular permeability in rats at a peroral dose of 100 mg/kg 1 hr prior to challenge	Rattus norvegicus	7		organism-based format	Scientific Literature
4.	ALA1794345	F	PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]	Plasmodium falciparum	170,142		organism-based format	PubChem BioAssays
5.	ALA1794580	F	PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]	Plasmodium falciparum	130,890		organism-based format	PubChem BioAssays
6.	ALA1614459	F	PUBCHEM_BIOASSAY: qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells. (Class of assay: confirmatory)	Drosophila	88,408		assay format	PubChem BioAssays
7.	ALA1614103	F	PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ]	Homo sapiens	11,883		assay format	PubChem BioAssays
8.	ALA1614211	F	PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory)		36,499		assay format	PubChem BioAssays
9.	ALA1614031	F	PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 1467, 2100, 2112, 1473, 1466 ]	Homo sapiens	11,883		assay format	PubChem BioAssays
10.	ALA1613933	B	PUBCHEM_BIOASSAY: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1484, AID504370, AID504374, AID504375]	Homo sapiens	7,185		protein format	PubChem BioAssays
11.	ALA2354287	F	PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory)		39,968		assay format	PubChem BioAssays
12.	ALA4409815	A	Cytotoxicity against human TE671 cells assessed as reduction in cell viability after 48 hrs by MTT assay	Homo sapiens	6		cell-based format	Scientific Literature
13.	ALA4409816	F	Antiviral activity against Japanese encephalitis virus infected in human TE671 cells assessed as reduction in virus-induced cytopathic effect at 10 to 100 uM treated immediately post-infection measured at 36 hrs post-infection by inverted microscopic analysis	Japanese encephalitis virus	6		organism-based format	Scientific Literature
14.	ALA4409817	F	Antiviral activity against Japanese encephalitis virus infected in human TE671 cells assessed as decline in infected cell apoptotic fraction by measuring proportion of cells at subG1 phase treated immediately post-infection measured at 36 hrs post-infection by PI-staining based flow cytometric analysis	Japanese encephalitis virus	6		organism-based format	Scientific Literature